Blood Cancer Treatment in Delhi-NCR

Acute Myeloid Leukemia is a fast-progressing cancer of the myeloid blood cells in the bone marrow, requiring prompt diagnosis and treatment. It is more common in adults and can affect the body's ability to produce healthy red blood cells, white blood cells, and platelets.

Acute Lymphoblastic Leukemia is a rapidly developing cancer of the lymphoid cells in the bone marrow. It is more frequently diagnosed in children but also occurs in adults, and requires timely, intensive treatment.

Chronic Myeloid Leukemia is a slower-progressing cancer of the myeloid cells, often associated with a specific genetic mutation. It is typically diagnosed in adults and is generally managed effectively with long-term targeted therapy.

Chronic Lymphocytic Leukemia is a slow-growing cancer affecting lymphocytes, a type of white blood cell. It most commonly affects older adults and is often monitored closely, with treatment initiated based on disease progression and symptoms.

Hodgkin Lymphoma is a cancer of the lymphatic system marked by the presence of abnormal cells called Reed-Sternberg cells. It can affect people of any age and is generally associated with high treatment success rates when diagnosed early.

Non-Hodgkin Lymphoma refers to a diverse group of lymphatic system cancers arising from B-cells or T-cells. It varies widely in how it behaves and progresses, and treatment is tailored to the specific subtype and stage.

Multiple Myeloma is a cancer of the plasma cells in the bone marrow that affects blood counts, bone strength, and kidney function. It most commonly affects older adults and requires ongoing, specialized management.

Myelodysplastic Syndrome is a group of disorders caused by poorly formed or dysfunctional blood cells in the bone marrow. It can lead to low blood counts and, in some cases, progress to acute leukemia if left untreated.

Myeloproliferative Neoplasms are a group of disorders, including Polycythemia Vera, Essential Thrombocythemia, and Myelofibrosis, in which the bone marrow produces too many blood cells. These conditions develop gradually and require risk-based, long-term management.

Plasma Cell Disorders are a broader category of conditions involving abnormal plasma cell growth, including precursor states that may develop into multiple myeloma. These conditions require careful monitoring and staged treatment based on how they progress over time.

A CBC measures the levels of red blood cells, white blood cells, and platelets, often serving as the first indicator of a possible blood cancer.

A bone marrow biopsy involves examining a small sample of bone marrow to assess abnormal cell growth and confirm a blood cancer diagnosis.

Flow cytometry analyzes specific characteristics of blood or bone marrow cells to identify and classify different types of blood cancer.

Molecular and genetic testing detects specific mutations or chromosomal changes that help determine the exact subtype of blood cancer and guide treatment decisions.

A PET-CT scan combines imaging techniques to detect the presence, location, and extent of blood cancer within the body, particularly useful in lymphoma staging.

Ultrasound and other imaging techniques help assess lymph nodes, organs, and other structures that may be affected by blood cancer.

Targeted therapy uses medications designed to act on specific genetic mutations or proteins involved in cancer cell growth. It works by interfering with the particular pathways that allow cancer cells to survive and multiply, and is suitable for patients whose blood cancer has an identifiable molecular target, such as certain cases of CML or AML.

CAR T-Cell Therapy is an advanced form of immunotherapy that involves modifying a patient's own T-cells to better recognize and destroy cancer cells. It works by re-engineering these cells in a lab and reintroducing them into the body, and is typically considered for patients with certain relapsed or treatment-resistant blood cancers.

Supportive care encompasses treatments that manage symptoms, side effects, and complications arising from blood cancer or its treatment, including blood transfusions. It works by maintaining blood counts, preventing infections, and improving overall well-being, and is an important part of care for patients undergoing active treatment or recovery.